A66T (p.Ala66Thr) variant of MAGED2 (Melanoma-associated antigen D2)
A66T (p.Ala66Thr) in MAGED2 (Melanoma-associated antigen D2) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.24 / 1. The record also includes population frequency data, published literature, and structural context.
A66T (p.Ala66Thr) variant details
- p.Ala66Thr
- gnomAD X-54809872-G-A
- Missense
- Variant Prioritization Score for Impact Estimate 0.239
- REVEL 0.05
- CADD 20.70
- PolyPhen-2 0.97
- SIFT 0.07
- Population evidence available
- Structural context available
- Literature evidence available